Identification of diagnostic and progression biomarkers of neurodegenerative diseases

Identification of diagnostic and progression biomarkers of neurodegenerative diseases - Biomarkers for neurodegenerative diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034525

Enrollment

Registered

2018-10-16

Start date

2018-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ALS, Parkinson&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients admitted to Shiga University hospital, Neurology department, with the suspected diagnosis of the following diseases; ALS, Parkinson's disease, PSP, CBS, MSA(including SCD), cerebral infarction, normal pressure hydrocephalus, inflammatory neuropathy.

Exclusion criteria

Exclusion criteria: Any person under 16 years old. Pregnant patients.

Design outcomes

Primary

Measure	Time frame
lymphocyte subset, immunophenotype,	—

Secondary

Measure	Time frame
NF-H, NF-L, inflammatory markers, chromogranins (A, B), carbonylated proteins	—

Countries

Japan

Contacts

Public ContactMakoto Urushitani

Shiga University of Medical Science Department of Neurology

hqsinkei@belle.shiga-med.ac.jp077-548-2160

Outcome results